Jason Grady

Interim Chief Executive Officer

DSS, Inc.

275 Wiregrass Pkwy, West Henrietta, NY 14586

www.dssworld.com | NYSE American: DSS

DSS focuses on operating business segments in blockchain security, consumer, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. The DSS business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs.

Jason Grady serves as the Interim Chief Executive Officer of DSS, Inc., and concurrently holds the position of President at Premier Packaging Corporation, a wholly owned subsidiary of DSS, Inc. Additionally, Jason is an integral member of the DSS Executive Committee, contributing his expertise in various board and officer roles within the company. These include serving as CEO and Director of DSS Biohealth Holdings, President and COO of DSS Financial Management, COO & Director of HWH World, COO and Director of USX Securities, and Chief Business Officer of Impact Bio Medical, among others. With over 25 years of experience navigating the forefront of business growth and industry dominance, Jason has played a pivotal role in propelling DSS into the successful, global portfolio company it is today.

Heather Fritzsche

heatherf@spearheadglobal.com

Heather Fritzsche is the co-founder of Spearhead Global, an innovative packaging solutions provider. Included on the Inc 5000 list, Spearhead Global now operates in the United States, Mexico, Italy, and India.

With a career spanning over two decades, Heather has been instrumental in redefining the spirits industry, working with iconic brands to create award-winning packaging that stands out on shelves and elevates the customer experience. As the owner of a certified Women’s Business Enterprise, Heather is known for disrupting the industry with revolutionary ideas that challenge the status quo.

Website: www.kleinerlabs.com

Dr. Kleiner is a Denver, CO native who trained at Stanford University, University of Colorado, Rush/Presbyterian-St. Luke’s Hospital in Chicago and University of CA at San Diego for pre-medical, medical and residency training. He was an NIH postdoctoral fellow in the biochemistry of tendons and ligaments and fellowship trained in adult and pediatric reconstructive spinal surgery at Colorado Spine Center and the University of Colorado. He is renowned for his compassion, medical knowledge, skill as a surgeon, and as a teacher and scholar.

Dr. Kleiner is a devotee of minimally invasive strategies for spinal surgery and has contributed to the armamentarium of instrumentation, strategies and intellectual property in this area with over 60 issued patents. He is the founder and CEO of Kleiner Device Labs (KDL) and an Assistant Clinical Professor at The University of Colorado Health Sciences Center. He has concentrated his efforts on commercializing the intellectual property portfolio of KDL and has succeeded in procuring FDA clearance, market acceptance, and sales of two spinal surgical devices designed to improve patient outcomes, simplify complex surgeries, reduce the risk of complications, and make good surgeons better.

AgEagle Aerial Systems Inc.

bill.irby@ageagle.com.

https://ageagle.com/

NYSE Symbol: UAVS

Prior to joining AgEagle as President, Bill Irby served as President of MTI Motion, a Steel Partners company specializing in motors and hardware for aircraft, weapons systems, and commercial equipment from November 2022 to February 2024. He has a long career spanning several executive roles in innovative defense organizations. Bill served as the Chief Operating Officer at Martin UAV (assisting in its acquisition by Shield AI) from March 2021 to December 2021, President of the Reconnaissance Mission Systems sector of L3Harris Technologies from October 2018 to February 2021, SVP/GM of Textron Systems’ Unmanned Systems business from November 2012 to October 2018, and as VP of two business units at Northrop Grumman in Intelligence, Surveillance, and Reconnaissance (ISR) and Tactical Communications.

Bill is married, with three children, and lives in the Dallas/Fort Worth area.

Mr. Ordan Trabelsi

ir@supercom.com

https://www.supercom.com/

Mr. Ordan Trabelsi joined SuperCom in June 2013. Ordan has over 15 years of experience as CEO growing high tech companies globally. He also has experience in research and development, product innovation, go-to-market strategies and leadership of global multi-disciplinary teams, as well as hands-on technology experience in cyber security, encryption, advanced mathematics, and mobile and internet networks technologies, along with experience in strategic mergers and acquisitions and product strategies.

Prior to joining SuperCom, he has served as the co-founder and CEO of Klikot Inc, a global social networking company.

​Ordan holds an MBA from Columbia University Business School, New York, and a BSc in Computer Engineering from The Technion: Israel Institute of Technology.

Ezra Beyman

Chairman and CEO

Reliance Global Group Inc.

NASDAQ: RELI

https://relianceglobalgroup.com/

732-380-4600

Mr. Beyman brings nearly three decades of entrepreneurial experience in real estate and ten years in insurance. His portfolio of commercial and residential properties at one point consisted of more than 40,000 residential units, as well as several insurance companies. In 1985, he founded his first mortgage brokerage, which rapidly grew into the third largest licensed mortgage brokerage in America by 2008. He also expanded to real estate acquisition, having grown his portfolio at one point, to over three billion dollars.

Investor Relations

Brett Maas

HaydenIR

480-861-2425

NanoVibronix, Inc. (Nasdaq: NAOV) is a medical device company headquartered in Tyler, Texas, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety to medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The Company’s primary products include PainShield® and UroShield®, which are portable devices suitable for administration at home without assistance of medical professionals. Additional information about NanoVibronix is available at: www.nanovibronix.com .

Greg Lambrecht

CEO & Chairman of the Board

Visionary entrepreneur backed by a robust tenure in company operations, investor relations, and corporate leadership, has a successful track record in founding and leading start-up companies. As the founder of PCI, a leading consumer product distribution company, Greg negotiated agreements with the nation’s largest retail outlets such as 7-11 (Southland Corp), Albertson’s, and Costco representing 25,000 retail accounts. Greg led PCI through a NASDAQ listed IPO, raising $10,000,000. Greg is a graduate of Western Washington University with a degree in marketing communications.

Since taking PCI public, Greg did a reverse merger in 2011 into a company now called Singlepoint. Greg resigned as Chairman/CEO/Director and spun out 1606 Corp (Doing Business AS 1606 Corp) as a public company from Singlepoint. Greg has now taken three companies public, raising millions of dollars in the process.